GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,000 | +100.0% | 10 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 10 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $2,000 | 0.0% | 10 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $2,000 | +100.0% | 10 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -80.0% | 10 | -80.0% | 0.00% | -100.0% |
| Q2 2017 | $5,000 | -16.7% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $6,000 | -14.3% | 50 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $7,000 | +40.0% | 50 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $5,000 | +25.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $4,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|